Search This Blog

Wednesday, February 5, 2020

Arrowhead FQ1 revenue matches views

Arrowhead Pharmaceuticals (NASDAQ:ARWR) fiscal Q1 results:
Revenue: $29.5M (-15.0%), in line with consensus.
Net loss: ($2.7M); loss/share: ($0.03).
Arrowhead Pharmaceuticals EPS beats by $0.04, beats on revenue
https://seekingalpha.com/news/3538817-arrowhead-fq1-revenue-matches-views
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)